Sale disclosed
Bryan Supran
EVP, CLO and Secretary
Common Stock
- Reported value
- $398.86K
- Reported price
- $226.88 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
ALNYLAM PHARMACEUTICALS, INC.
Last 30 daysNo qualifying insider buying. Sales: $398.86K by 1 insider.
Showing the first 6 of 44 trades on this page.
EVP, CLO and Secretary
Common Stock
Chief Executive Officer
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price. That is not a current market valuation; inspect the original filing for context.
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
Director
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chief Human Resources Officer
Common Stock
Chief Human Resources Officer
Common Stock
Chief Human Resources Officer
Common Stock
Chief Human Resources Officer
Common Stock
Chief Human Resources Officer
Common Stock
Chief Human Resources Officer
Common Stock
Chief Human Resources Officer
Common Stock
Chief Human Resources Officer
Common Stock
Chief Human Resources Officer
Common Stock
Chief Human Resources Officer
Common Stock
Chief Human Resources Officer
Common Stock
Chief Human Resources Officer
Common Stock
Chief Human Resources Officer
Common Stock
Chief Human Resources Officer
Common Stock
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| EVP, CLO and Secretary | Common StockSale | 1,758$226.88 / share | $398.86K | Oct 2Filed Oct 6 · 4d later | SEC filing |
| Chief Executive Officer | Common StockGrant or award | 107Award · no purchase price | Non-cash award | Sep 19Filed Sep 22 · 3d later | SEC filing |
| Director | Common StockOption exercise or conversion10b5-1 | 3,830$0 reported · see filing | Not established | Jun 1Filed Jun 3 · 2d later | SEC filing |
| Director | Common StockSale10b5-15 trades | 3,830avg $299.18 / share | $1.15M | Jun 1Filed Jun 3 · 2d later | 5 filings
|
| Director | Stock Option (Right to Buy)Option exercise or conversion10b5-1 | Derivative units3,830$70.20 exercise / conversion price | Not a separate purchase | Jun 1Filed Jun 3 · 2d later | SEC filing |
| Director | Stock Option (Right to Buy)Grant or award | Derivative units4,393Award · no purchase price | Non-cash award | Jun 1Filed Jun 3 · 2d later | SEC filing |
| Director | Common StockGrant or award | 671Award · no purchase price | Non-cash award | May 20Filed May 22 · 2d later | SEC filing |
| Director | Stock Option (Right to Buy)Grant or award | Derivative units1,441Award · no purchase price | Non-cash award | May 20Filed May 22 · 2d later | SEC filing |
| Director | Common StockGrant or award | 838Award · no purchase price | Non-cash award | May 20Filed May 22 · 2d later | SEC filing |
| Director | Stock Option (Right to Buy)Grant or award | Derivative units1,802Award · no purchase price | Non-cash award | May 20Filed May 22 · 2d later | SEC filing |
| Director | Common StockGrant or award | 671Award · no purchase price | Non-cash award | May 20Filed May 22 · 2d later | SEC filing |
| Director | Stock Option (Right to Buy)Grant or award | Derivative units1,441Award · no purchase price | Non-cash award | May 20Filed May 22 · 2d later | SEC filing |
| Director | Common StockGrant or award | 671Award · no purchase price | Non-cash award | May 20Filed May 22 · 2d later | SEC filing |
| Director | Stock Option (Right to Buy)Grant or award | Derivative units1,441Award · no purchase price | Non-cash award | May 20Filed May 22 · 2d later | SEC filing |
| Director | Common StockGrant or award | 671Award · no purchase price | Non-cash award | May 20Filed May 22 · 2d later | SEC filing |
| Director | Stock Option (Right to Buy)Grant or award | Derivative units1,441Award · no purchase price | Non-cash award | May 20Filed May 22 · 2d later | SEC filing |
| Director | Common StockGrant or award | 671Award · no purchase price | Non-cash award | May 20Filed May 22 · 2d later | SEC filing |
| Director | Stock Option (Right to Buy)Grant or award | Derivative units1,441Award · no purchase price | Non-cash award | May 20Filed May 22 · 2d later | SEC filing |
| Director | Common StockGrant or award | 671Award · no purchase price | Non-cash award | May 20Filed May 22 · 2d later | SEC filing |
| Director | Stock Option (Right to Buy)Grant or award | Derivative units1,441Award · no purchase price | Non-cash award | May 20Filed May 22 · 2d later | SEC filing |
| Director | Common StockGrant or award | 671Award · no purchase price | Non-cash award | May 20Filed May 22 · 2d later | SEC filing |
| Director | Stock Option (Right to Buy)Grant or award | Derivative units1,441Award · no purchase price | Non-cash award | May 20Filed May 22 · 2d later | SEC filing |
| Director | Common StockGrant or award | 671Award · no purchase price | Non-cash award | May 20Filed May 22 · 2d later | SEC filing |
| Director | Stock Option (Right to Buy)Grant or award | Derivative units1,441Award · no purchase price | Non-cash award | May 20Filed May 22 · 2d later | SEC filing |
| Director | Common StockOption exercise or conversion | 11,250$70.20 / share | $789.75K | May 13Filed May 14 · 1d later | SEC filing |
| Director | Stock Option (Right to Buy)Option exercise or conversion | Derivative units11,250$70.20 exercise / conversion price | Not a separate purchase | May 13Filed May 14 · 1d later | SEC filing |
| Chief Human Resources Officer | Common StockSale10b5-19 trades | 1,624avg $319.59 / share | $519.01K | Apr 2Filed Apr 7 · 5d later | 9 filings
|
| Chief Human Resources Officer | Common StockSale10b5-15 trades | 2,286avg $330.42 / share | $755.33K | Apr 6Filed Apr 7 · 1d later | 5 filings
|
No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
Alnylam Pharmaceuticals, Inc. - Common Stock · Stock
The filing reports a full sale for a spouse.
Cory A BookerReporting Senate member